Dr Daniel Ajzensztejn
FRCR, MRCP, DPhil (PhD), MSc Oncology, BSc Pharmacology, MBBS
Consultant Clinical Oncologist
Languages spoken
English
Expert in
Lung cancer, Skin cancer, SABR
Overview
.svg){kind=icon}
Career positions
- Consultant Clinical Oncologist and Oxford University Hospitals and Milton Keynes University Hospital
Dr Daniel Ajzensztejn is a Consultant Clinical Oncologist specialising in the treatment of lung cancers, mesothelioma, skin cancers and stereotactic radiotherapy (SABR) for primary lung cancer and metastases. He has a particular interest in cutting edge personalised treatments including stereotactic ablative radiotherapy (SABR/SBRT) and immunotherapy.
Dr Ajzensztejn studied medicine at University College London and has undertaken several other degrees relevant to his specialty including a DPhil (PhD) at Oxford University where his research focused on ways to use the body's own immune system to fight cancer. He continues to be involved in clinical research and is the principle investigator for a number of clinical trials.
He is an NHS consultant at Oxford University Hospitals, and also undertakes an NHS clinic at Milton Keynes University Hospital. He sees private patients at GenesisCare Oxford and GenesisCare Milton Keynes.
Expertise and interests
- Lung cancer
- Skin cancer
- Mesothelioma
- Stereotactic radiotherapy (SABR)
- Harnessing the immune system to reject cancers through genetic modifications of tumour cells. Combining immunotherapy with radiotherapy.
- lung cancer, lung malignancies, skin cancer radiotherapy, Stereotactic Ablative Body Radiotherapy, SABR, IMRT, Conformal Radiotherapy, Mesothelioma
Qualifications
- FRCR Clinical Oncology · Royal College of Radiologists
- DPhil (PhD) · Tumour Immunology · Oxford University
- MSc Oncology · Institute of Cancer Research · University of London
- MRCP · Royal College of Physicians of London
- MBBS Medicine · University College London
- BSc Pharmacology · University College London